123 results
8-K
EX-99.1
SIENQ
Sientra Inc
13 Feb 24
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
9:00am
the value of our broad product portfolio and legacy in plastic surgery. In the interim, we remain focused on providing our customers with quality service … , preferred and recommended scar gel of plastic surgeons (*).
Sientra uses its investor relations website to publish important information about
8-K
SIENQ
Sientra Inc
29 Jan 24
Entry into a Material Definitive Agreement
6:07am
, the reception of plastic surgeons to the Company’s products, the Company’s ability to expand into aesthetic applications outside of breast procedures … in the plastic surgery market, and the Company’s ability to obtain and execute on any strategic alternatives. Such statements are subject to risks
8-K
SIENQ
Sientra Inc
16 Jan 24
Entry into a Material Definitive Agreement
4:10pm
with AuraClens™ fat transfer system and SimpliDerm® human Acellular Dermal Matrix into its existing operations, the reception of plastic surgeons … products and strategic partnerships, the Company’s ability to capture additional market share and customer accounts in the plastic surgery market
8-K
EX-99.1
SIENQ
Sientra Inc
9 Nov 23
Sientra Reports THIRD Quarter FINANCIAL and operational Results
4:14pm
for the same period in 2022.
Presented at the American Society of Plastic Surgeons meeting in Austin, Texas, unparalleled 12-month interim clinical data … and profitability."
“We are extremely excited about the interim 12-month clinical data on our Viality long-term retention study presented at Plastic Surgery
8-K
h5dg1
31 Oct 23
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial
6:12am
8-K
EX-99.1
72y2aqzyt95a5qj
31 Oct 23
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial
6:12am
8-K
EX-99.1
5k2y50p7c0
10 Aug 23
Sientra Reports RECORD Second Quarter FINANCIAL and operational Results
4:22pm
8-K
EX-99.1
y5uu bwaw2ob1e
11 May 23
Sientra Reports Record First Quarter 2023 Operational Results
4:21pm
8-K
EX-99.1
mycrt
30 Mar 23
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market with New Product Launches
4:21pm
8-K
EX-99.1
w2psnbqibvo 0v
10 Nov 22
Sientra Reports Record Third Quarter 2022 Financial Results
4:08pm
8-K
EX-99.2
3feenm8gfb bgidr59
27 Oct 22
Sientra Announces Proposed Public Offering
4:28pm
8-K
EX-99.1
i73rgo5c
27 Oct 22
Sientra Announces Proposed Public Offering
4:28pm
424B5
ivrvng67
24 Oct 22
Prospectus supplement for primary offering
4:22pm